摘要
目的 研究脑梗死治疗中给予奥拉西坦与丹红联合治疗的临床治疗效果。方法 采用抽签分组方式对我院在2014年3月~2016年3月收治的88例脑梗死患者进行分组研究,即对照组和实验组,将治疗后的效果进行对比分析。结果 相较于对照组,实验组患者的治疗总有效率较高,同时神经功能缺损评分较优,各项差异具有统计学意义(P〈0.05)。结论 在脑梗死治疗中采用奥拉西坦与丹红联合治疗效果确切。
Objective To study the clinical effect of oxiracetam and Danhong combined therapy of cerebral infarction. Methods 88 cases of cerebral infarction treated in our hospital from March 2014 to March 2016 were divided into two groups, namely the control group and the experimental group. The effect after treatment was compared and analyzed. Results Compared with the control group, the total effective rate of treatment in the experimental group was higher than that of the neurological functional defect, and the differences were statistically significant (P〈0.05). Conclusion In the treatment of cerebral infarction, oxiracetam and Danhong have exact treatment effect.
出处
《中国继续医学教育》
2016年第29期182-184,共3页
China Continuing Medical Education
关键词
奥拉西坦
丹红
脑梗死
联合治疗
Oxiracetam, Danhong, Cerebral infarction, Combination therapy